安捷伦将以2.4亿美元收购病理学软件开发商Proscia

路透中文
Oct 13
安捷伦将以2.4亿美元收购病理学软件开发商Proscia

路透10月13日 - 安捷伦科技(A.N)周二表示,将以2.4亿美元现金加最高3000万美元(与未来业绩目标挂钩)收购病理学软件制造商Proscia,此举标志着这家实验室设备制造商正进一步推进其在人工智能辅助诊断领域的布局。

以下是更多细节:

  • 私营公司Proscia开发的软件可将病理切片转换为数字图像,这些图像可通过人工智能工具进行存储、审查和分析

  • 安捷伦表示,此次收购将增强其病理业务实力,并扩大其在数字化及人工智能辅助诊断领域的业务版图

  • 此项交易将使安捷伦获得一家高增长的软件业务,该业务在过去12个月内创造了超过1800万美元的收入

  • 两家公司自2022年起便展开合作,当时双方签署了一项为期多年的分销协议,共同提供将安捷伦病理产品与Proscia软件相结合的数字病理系统

  • 该交易预计将于安捷伦 财年2027年初完成

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10